tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

REPL Stock Latest News

Replimune Group Secures Funding for Cancer Treatment Expansion
Company AnnouncementsReplimune Group Secures Funding for Cancer Treatment Expansion
23d ago
8K
REPL
Replimune Group to sell 5.67M shares at $8.82 in private placement
PremiumThe Fly
Replimune Group to sell 5.67M shares at $8.82 in private placement
23d ago
REPL
Replimune Announces $100 Million Private Placement Financing
PremiumPress Releases
Replimune Announces $100 Million Private Placement Financing
23d ago
REPL
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
26d ago
BCDA
GERN
Replimune to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
PremiumPress Releases
Replimune to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
29d ago
REPL
Replimune Group price target raised to $17 from $12 at H.C. Wainwright
PremiumThe FlyReplimune Group price target raised to $17 from $12 at H.C. Wainwright
29d ago
REPL
Replimune Group price target raised to $17 from $13 at Barclays
PremiumThe Fly
Replimune Group price target raised to $17 from $13 at Barclays
29d ago
REPL
Replimune Group’s IGNYTE Trial Shows Promising Melanoma Outcomes
PremiumCompany Announcements
Replimune Group’s IGNYTE Trial Shows Promising Melanoma Outcomes
1M ago
8K
REPL
Replimune Announces Positive Topline Primary Analysis Data by Independent Central Review from IGNYTE Clinical Trial of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma
PremiumPress Releases
Replimune Announces Positive Topline Primary Analysis Data by Independent Central Review from IGNYTE Clinical Trial of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma
1M ago
REPL
Replimune Group announces topline results from primary analysis of IGNYTE trial
PremiumThe Fly
Replimune Group announces topline results from primary analysis of IGNYTE trial
1M ago
REPL
Replimune Group presents positive data from RP1 and RP2 programs at ASCO
PremiumThe Fly
Replimune Group presents positive data from RP1 and RP2 programs at ASCO
1M ago
REPL
Replimune to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
PremiumPress Releases
Replimune to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
1M ago
REPL
Replimune Reports Fiscal Fourth Quarter and Year Ended 2024 Financial Results and Provides Corporate Update
PremiumPress ReleasesReplimune Reports Fiscal Fourth Quarter and Year Ended 2024 Financial Results and Provides Corporate Update
2M ago
REPL
Replimune Group expects cash to fund operations into 2Q26
PremiumThe Fly
Replimune Group expects cash to fund operations into 2Q26
2M ago
REPL
Replimune Group reports 2024 EPS ($3.24), consensus ($3.27)
PremiumThe Fly
Replimune Group reports 2024 EPS ($3.24), consensus ($3.27)
2M ago
REPL
Is REPL a Buy, Before Earnings?
PremiumPre-Earnings
Is REPL a Buy, Before Earnings?
2M ago
REPL
Replimune Group presents interim results from ARTACUS trial of RP1 monotherapy
PremiumThe Fly
Replimune Group presents interim results from ARTACUS trial of RP1 monotherapy
3M ago
REPL
Interim Results from the ARTACUS Clinical Trial of RP1 Monotherapy in Solid Organ and Hematopoietic Cell Transplant Recipients with Skin Cancers Presented During Oral Presentation at the American Association of Cancer Research (AACR) 2024 Annual Meeting
PremiumPress Releases
Interim Results from the ARTACUS Clinical Trial of RP1 Monotherapy in Solid Organ and Hematopoietic Cell Transplant Recipients with Skin Cancers Presented During Oral Presentation at the American Association of Cancer Research (AACR) 2024 Annual Meeting
3M ago
REPL
Replimune Group announces inducement grants under Nasdaq listing rule
PremiumThe Fly
Replimune Group announces inducement grants under Nasdaq listing rule
3M ago
REPL
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress ReleasesReplimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3M ago
REPL
Replimune Group Announces Major Executive Team Overhaul
PremiumCompany Announcements
Replimune Group Announces Major Executive Team Overhaul
3M ago
8K
REPL
Replimune Announces Appointment of Sushil Patel to CEO and Executive Leadership Transitions
PremiumPress Releases
Replimune Announces Appointment of Sushil Patel to CEO and Executive Leadership Transitions
3M ago
REPL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >